Vanta Bioscience Ltd (540729)
Latest quarterly results (H2 FY26)
In its latest reported quarter, H2 FY26, Vanta Bioscience's revenue was ₹1.5 Cr (+357.6% year on year, +403.3% on the previous half-year), and net profit ₹1.9 Cr (against a loss a year earlier); the operating margin was 92.1%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹1.5 | +357.6% | +403.3% |
| Operating profit | ₹1.4 | from loss | from loss |
| Net profit | ₹1.9 | from loss | from loss |
| EPS (₹) | 2.71 | from loss | from loss |
| Operating margin | 92.1% | — | — |
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
